Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1981 Feb;42(2):201–206.

The mechanism of T-cell mediated cytotoxicity. VIII. Zeiosis corresponds to irreversible phase (programming for lysis) in steps leading to lysis.

C J Sanderson
PMCID: PMC1458082  PMID: 6970176

Abstract

The combined use of an improved technique for inactivating cytotoxic T cells during the lytic reaction, with time lapse cinematography and isotope release assay, have shown that the initiation of the morphological phase of zeiosis corresponds to the time when the target cell is irreversibly programmed to lyse. It is suggested that rubidium release occurs during the phase of zeiosis. The rate of release of chromium is the result of two phases of variable length, The reversible phase (before programming for lysis) and the irreversible phase from the initiation of zeiosis to the final lytic event. The time required for programming for lysis to occur depends on the number of T cells reacting with the target cell. Thus at high ratios in tubes, where multiple interactions are possible, most target cells are programmed to lyse within 10 min. However, under conditions when T-cell:target-cell conjugates are kept in suspension to prevent multiple interactions, programming for lysis can take several hours. This provides an explanation for the apparent difference in timing of zeiosis and programming for lysis in previous publications. It is also shown that further T-cell interactions with the target cell after programming for lysis (i.e. during the irreversible phase), markedly influence the rate of chromium release. This provides an explanation for the fact that chromium release takes at least 3 h to reach plateau levels after inactivation of the T cells, whereas at high effector cell ratios, maximum levels of chromium release can occur within 1 h.

Full text

PDF
201

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berke G., Sullivan K. A., Amos B. Rejection of ascites tumor allografts. II. A pathway for cell-mediated tumor destruction in vitro by peritoneal exudate lymphoid cells. J Exp Med. 1972 Dec 1;136(6):1594–1604. doi: 10.1084/jem.136.6.1594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cerottini J. C., Brunner K. T. Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Adv Immunol. 1974;18:67–132. doi: 10.1016/s0065-2776(08)60308-9. [DOI] [PubMed] [Google Scholar]
  3. Grimm E. A., Bonavida B. Studies of the induction and expression of T cell mediated immunity. VI. Heterogeneity of lytic efficiency exhibited by isolated cytotoxic T lymphocytes prepared from highly enriched populations of effector-target conjugates. J Immunol. 1977 Sep;119(3):1041–1047. [PubMed] [Google Scholar]
  4. Grimm E., Bonavida B. Mechanism of cell-mediated cytotoxicity at the single cell level. I. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency. J Immunol. 1979 Dec;123(6):2861–2869. [PubMed] [Google Scholar]
  5. Lake P., Clark E. A., Khorshidi M., Sunshine G. H. Production and characterization of cytotoxic Thy-1 antibody-secreting hybrid cell lines. Detection of T cell subsets. Eur J Immunol. 1979 Nov;9(11):875–886. doi: 10.1002/eji.1830091109. [DOI] [PubMed] [Google Scholar]
  6. Martz E., Benacerraf B. An effector-cell independent step in target cell lysis by sensitized mouse lymphocytes. J Immunol. 1973 Nov;111(5):1538–1545. [PubMed] [Google Scholar]
  7. Martz E. Early steps in specific tumor cell lysis by sensitized mouse T lymphocytes. I. Resolution and characterization. J Immunol. 1975 Jul;115(1):261–267. [PubMed] [Google Scholar]
  8. Martz E. Early steps in specific tumor cell lysis by sensitized mouse T lymphocytes. II. Electrolyte permeability increase in the target cell membrane concomitant with programming for lysis. J Immunol. 1976 Sep;117(3):1023–1027. [PubMed] [Google Scholar]
  9. Martz E. Mechanism of specific tumor-cell lysis by alloimmune T lymphocytes: resolution and characterization of discrete steps in the cellular interaction. Contemp Top Immunobiol. 1977;7:301–361. doi: 10.1007/978-1-4684-3054-7_9. [DOI] [PubMed] [Google Scholar]
  10. Sanderson C. J., Taylor G. A. The kinetics of Cr release from target cells in cell mediated cytotoxicity and the relationship to the kinetics of killing. Cell Tissue Kinet. 1975 Jan;8(1):23–32. doi: 10.1111/j.1365-2184.1975.tb01203.x. [DOI] [PubMed] [Google Scholar]
  11. Sanderson C. J. The mechanism of T cell mediated cytotoxicity. I. The release of different cell components. Proc R Soc Lond B Biol Sci. 1976 Jan 20;192(1107):221–239. doi: 10.1098/rspb.1976.0010. [DOI] [PubMed] [Google Scholar]
  12. Sanderson C. J. The mechanism of T cell mediated cytotoxicity. II. Morphological studies of cell death by time-lapse microcinematography. Proc R Soc Lond B Biol Sci. 1976 Jan 20;192(1107):241–255. doi: 10.1098/rspb.1976.0011. [DOI] [PubMed] [Google Scholar]
  13. Sanderson C. J., Thomas J. A. The mechanism of T cell mediated cytotoxicity. III. Changes in target cell susceptibility during the cell cycle. Proc R Soc Lond B Biol Sci. 1976 Oct 29;194(1116):417–429. doi: 10.1098/rspb.1976.0086. [DOI] [PubMed] [Google Scholar]
  14. Wagner H., Röllinghoff M. T cell-mediated cytotoxicity: discrimination between antigen recognition, lethal hit and cytolysis phase. Eur J Immunol. 1974 Nov;4(11):745–750. doi: 10.1002/eji.1830041108. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES